Relationship Between Pretreatment Body Composition and Clinical Outcomes in Patients With Metastatic Renal Cell Carcinoma Receiving First-Line Ipilimumab Plus Nivolumab
Title:
Relationship Between Pretreatment Body Composition and Clinical Outcomes in Patients With Metastatic Renal Cell Carcinoma Receiving First-Line Ipilimumab Plus Nivolumab
Author:
McManus, Hannah D. Zhang, Dylan Schwartz, Fides R. Wu, Yuan Infield, Jordan Ho, Ethan Armstrong, Andrew J. George, Daniel J. Kruse, Danielle Gupta, Rajan T. Harrison, Michael R.